The shares of Namita Thapar’s company McMaur Pharmaceuticals, who were seen as a judge in the shark tank India, saw an increase of 8 percent in the day on 6 October. The price on BSE went up to Rs 1448 high. At the end of trading, the stock gained 7 percent to settle at Rs 1434.50.
Emcure Pharma had told the stock markets on Friday, 3 October that it had purchased 4,095,180 shares or 20.42 percent stake from individual shareholders in subsidiary Juventus Healthcare Limited. The deal was Rs 724.90 crore.
Now Juventus has become a complete ownership subsidiary of Mesure Pharma. The purchase was approved by the Board of Makor Pharma in June 2025. Prior to this deal, the company had a 79.58 percent stake in Juventus. After the new deal, the purchase in the shares of Makor Pharma increased.
The face value of the shares of Makor Pharma is Rs 10. The company had 77.91 percent stake in the company by 30 June 2025. The company was listed in the stock market in July 2024. Its Rs 1,952.03 crore IPO was filled 67.87 times. The market cap is more than Rs 27100 crore.
Namita Thapar is a hole time director in the company. The stock has been stronger in 3 months and more than 12 percent in just one week. The face value of the stock is Rs 10. McMure Pharma gave a final dividend of Rs 3 per share for FY 2025.